Guidance for clinical variant classification in genes for spliceosomal small nuclear RNAs
DSouza, E. N.; Blakes, A. J.; Paluch, R.; Banka, S.; Chopra, M.; Coffey, A. J.; Depienne, C.; Galej, W. P.; Mazoyer, S.; Nava, C.; O'Donnell Luria, A.; O'Toole, J.; Riestra Crespo, P.; Rivolta, C.; Sanders, S. J.; Whiffin, N.
Show abstract
Background: Small nuclear RNAs (snRNAs) are RNA components of the major and minor spliceosomes that play a core role in splice-site recognition and control of the splicing process. Variants in genes that produce snRNAs are increasingly recognised as major contributors to rare disorders, including neurodevelopmental disorders (NDD) and retinal dystrophies (collectively termed RNUopathies, a subset of spliceosomopathies). Clinical interpretation of variants in snRNAs is, however, challenging and existing guidance to support clinical variant classification does not adequately capture the unique features of snRNAs that necessitate a bespoke approach. Methods: We quantified the elevated background mutation rate in snRNA genes using de novo variants from 12,007 trios and assessed mutation density in 76,215 genome sequenced individuals in gnomAD. We convened a panel of clinical, research, and industry scientists with wide-ranging expertise in clinical variant interpretation and classification and expert knowledge in snRNA genes to draft and refine a guidance document. Results: We detail important considerations for variant classification in snRNA genes. These include: the difficulties of variant identification which requires genome or targeted sequencing approaches, the large number of gene paralogs with high sequence identity that complicate read mapping and variant calling, and historical inaccuracies in snRNA gene annotation. Further we show a ~50-fold increase in de novo mutation rate in snRNA genes compared to intergenic sequence and discuss the implications of this for variant classification. We provide a set of specific recommendations for classifying variants in snRNA genes. Finally, we introduce RNUdb, an interactive web-based tool to support snRNA variant annotation and classification. Conclusions: We provide the first guidance for clinical variant classification in snRNA genes and anticipate that this will support routine screening and analysis of snRNA genes in clinical genetic testing.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Towards robust clinical genome interpretation: developing a consistent terminology to characterize disease-gene relationships - allelic requirement, inheritance modes and disease mechanisms 91%
- Mapping RNA splicing variations in clinically-accessible and non-accessible tissues to facilitate Mendelian disease diagnosis using RNA-seq 90%
- One in seven pathogenic variants can be challenging to detect by NGS: An analysis of 450,000 patients with implications for clinical sensitivity and genetic test implementation 89%
Similar papers in this journal
- Consensus guidelines for eligibility assessment of pathogenic variants to antisense oligonucleotide treatments 92%
- Advanced variant classification framework reduces the false positive rate of predicted loss of function (pLoF) variants in population sequencing data 91%
- Clinical validation of RNA sequencing for Mendelian disorder diagnostics 90%
Similar papers in this journal
- RNA sequencing identifies a cryptic exon caused by a deep intronic variant in NDUFB10 resulting in isolated Complex I deficiency. 91%
- 5’ splice site GC>GT variants differ from GT>GC variants in terms of their functionality and pathogenicity 90%
- Splicing impact of deep exonic missense variants in CAPN3 explored systematically by minigene functional assay 89%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.